Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit http://www.bacterin.com.
New hires at Bacterin International, Inc.
Bacterin International, Inc. Activity on LinkedIn
-
Bacterin International, Inc. has a new Sales Representative
J.D. Cashman is now Sales Representative
-
Bacterin International, Inc. has a new Sales Representative
Devann Wedemeier is now Sales Representative, was Arena Football Assistant at Iowa Barnstormers
-
-
-
-
Bacterin International, Inc. has a new Direct Representative
Kristi Holt is now Direct Representative, was Pharmaceutical Sales Specialist at AstraZeneca
